Literature DB >> 27384131

Qualitative analysis of major constituents from Xue Fu Zhu Yu Decoction using ultra high performance liquid chromatography with hybrid ion trap time-of-flight mass spectrometry.

Chunyan Fu1,2, Zian Xia3, Yonghui Liu2, Hongmei Lu4, Zhimin Zhang1, Yang Wang3, Xiaqiong Fan1.   

Abstract

Xue Fu Zhu Yu Decoction, a famous formula that has been used for treating many blood stasis-caused diseases for many centuries, comprises 11 kinds of traditional Chinese medicines. A convenient, efficient, and rapid analytical method was developed to simultaneously determine the major compounds in this decoction. An ultra-high performance liquid chromatography with hybrid ion trap time-of-flight mass spectrometry method was used to rapidly separate and detect the major constituents of the decoction. Using this technique, we identified or tentatively identified 34 compounds, including 21 flavonoids, 5 terpenoids, 3 organic acids, 2 lactones, 1 alkaloid, 1 amino acid, and 1 cyanogenic glycoside. The MS analysis of these constituents was described in detail. Findings may contribute to future metabolic and pharmacokinetic studies of this medicine.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Major constituents; Qualitative analysis; Traditional Chinese medicine; Ultra-high performance liquid chromatography; Xue Fu Zhu Yu Decoction

Mesh:

Substances:

Year:  2016        PMID: 27384131     DOI: 10.1002/jssc.201600083

Source DB:  PubMed          Journal:  J Sep Sci        ISSN: 1615-9306            Impact factor:   3.645


  7 in total

1.  Xue-fu-Zhu-Yu decoction protects rats against retinal ischemia by downregulation of HIF-1α and VEGF via inhibition of RBP2 and PKM2.

Authors:  Shu-Qiu Tan; Xue Geng; Jorn-Hon Liu; Wynn Hwai-Tzong Pan; Li-Xiang Wang; Hui-Kang Liu; Lei Hu; Hsiao-Ming Chao
Journal:  BMC Complement Altern Med       Date:  2017-07-14       Impact factor: 3.659

2.  Xuefu zhuyu decoction improves cognitive impairment in experimental traumatic brain injury via synaptic regulation.

Authors:  Jing Zhou; Tao Liu; Hanjin Cui; Rong Fan; Chunhu Zhang; Weijun Peng; Ali Yang; Lin Zhu; Yang Wang; Tao Tang
Journal:  Oncotarget       Date:  2017-06-30

3.  Exploring Pharmacological Mechanisms of Xuefu Zhuyu Decoction in the Treatment of Traumatic Brain Injury via a Network Pharmacology Approach.

Authors:  Yuanyuan Zhong; Jiekun Luo; Tao Tang; Pengfei Li; Tao Liu; Hanjin Cui; Yang Wang; Zebing Huang
Journal:  Evid Based Complement Alternat Med       Date:  2018-10-04       Impact factor: 2.629

4.  The efficacy and safety of Xuefu Zhuyu Decoction combined Mifepristone in the treatment of Uterine leiomyoma: A protocol systematic review and meta-analysis.

Authors:  Shasha Shi; Qiaobo Ye; Chenghao Yu; Fu Peng
Journal:  Medicine (Baltimore)       Date:  2021-01-22       Impact factor: 1.889

5.  Simultaneous Analysis for Quality Control of Traditional Herbal Medicine, Gungha-Tang, Using Liquid Chromatography-Tandem Mass Spectrometry.

Authors:  Chang-Seob Seo; Hyeun-Kyoo Shin
Journal:  Molecules       Date:  2022-02-11       Impact factor: 4.411

6.  The Improvement of Cardiac and Endothelial Functions of Xue-Fu-Zhu-Yu Decoction for Patients with Acute Coronary Syndrome: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Shiqi Chen; Xiaoxiao Wu; Tong Li; Weiting Cheng; Xiaowan Han; Yang Li; Baofu Wang; Yu Teng; Mingjing Zhao; Yahong Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-10       Impact factor: 2.629

7.  Xuefu Zhuyu decoction improves neurological dysfunction by increasing synapsin expression after traumatic brain injury.

Authors:  Lin Zhu; Tao Tang; Rong Fan; Jie-Kun Luo; Han-Jin Cui; Chun-Hu Zhang; Wei-Jun Peng; Peng Sun; Xin-Gui Xiong; Yang Wang
Journal:  Neural Regen Res       Date:  2018-08       Impact factor: 5.135

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.